These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 757196)

  • 1. Serum growth hormone levels in acromegalic patients before and after treatment.
    Plaseski A; Petrovski K; Sestakov G
    God Zb Med Fak Skopje; 1978; 24():91-100. PubMed ID: 757196
    [No Abstract]   [Full Text] [Related]  

  • 2. Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients.
    Giannella-Neto D; Wajchenberg BL; Mendonça BB; Almeida SF; Macchione M; Spencer EM
    J Endocrinol Invest; 1988 Jan; 11(1):57-60. PubMed ID: 3361077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma levels of growth hormone and insulin in acromegaly].
    Derot M; Rosselin G; Assan R; Freychet P; Tchobroutsky G
    Ann Endocrinol (Paris); 1966; 27(6):776-83. PubMed ID: 5973131
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth-hormone-binding protein in patients with acromegaly.
    Amit T; Ish-Shalom S; Glaser B; Youdim MB; Hochberg Z
    Horm Res; 1992; 37(6):205-11. PubMed ID: 1292973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly.
    Dobrashian RD; O'Halloran DJ; Hunt A; Beardwell CG; Shalet SM
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):589-93. PubMed ID: 8334745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assay of urinary growth hormone in normal and acromegalic adults.
    Evans AJ; Willis DS; Wood PJ
    Clin Endocrinol (Oxf); 1991 Nov; 35(5):413-8. PubMed ID: 1814655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatotropic hormone level in acromegalic patients.
    Schokker RC
    Folia Med Neerl; 1969; 12(1):2-7. PubMed ID: 5768557
    [No Abstract]   [Full Text] [Related]  

  • 8. Serial assays of plasma growth hormone in treated and untreated acromegaly.
    Hunter WM; Gillingham FJ; Harris P; Kanis JA; McGurk FM; McLelland J; Strong JA
    J Endocrinol; 1974 Oct; 63(1):21-34. PubMed ID: 4417605
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypersecretion of growth hormone in an acromegalic of 25 years' duration.
    Teo SK; Cheah JS
    Med J Malaysia; 1973 Mar; 27(3):220-2. PubMed ID: 4268929
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma growth hormone studies in normal individuals and acromegalic patients.
    Garcia JF; Linfoot JA; Manougian E; Born JL; Lawrence JH
    J Clin Endocrinol Metab; 1967 Oct; 27(10):1395-402. PubMed ID: 6057820
    [No Abstract]   [Full Text] [Related]  

  • 11. Modifications in serum growth hormone concentration induced by sulpiride in acromegalic patients pretreated with dopamine, bromocriptine, and metergoline.
    Arosio M; Moriondo P; Travaglini P; Ambrosi B; Beck-Peccoz P; Puglisi FC; Secchi F; Faglia G
    J Clin Endocrinol Metab; 1980 Sep; 51(3):454-61. PubMed ID: 6773973
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of galanin on the growth hormone response to growth hormone-releasing hormone in acromegaly.
    Giustina A; Schettino M; Bodini C; Doga M; Licini M; Giustina G
    Metabolism; 1992 Dec; 41(12):1291-4. PubMed ID: 1281259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of beneficial response of serum GH in acromegalic patients treated with medroxyprogesterone acetate (MPA).
    Jackson IM; Ormston BJ
    J Clin Endocrinol Metab; 1972 Sep; 35(3):413-5. PubMed ID: 5051364
    [No Abstract]   [Full Text] [Related]  

  • 14. Benserazide effects on growth hormone, prolactin, and thyrotropin in normal and acromegalic man.
    Masturzo P; De Maria A; Murialdo G; Bonura ML; Zauli C; Polleri A
    J Clin Endocrinol Metab; 1985 Aug; 61(2):378-81. PubMed ID: 4008612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid function in acromegaly.
    Aloia J; Powell D; Mendizibal E; Roginsky M
    Horm Res; 1975; 6(3):145-9. PubMed ID: 1218855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjects.
    Ferrari C; Barbieri C; Caldara R; Rampini P; Paracchi A; Boghen M; Rauhe WG
    Clin Pharmacol Ther; 1983 Jul; 34(1):74-8. PubMed ID: 6861440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The content of somatotropic hormone, inorganic phosphorus and nonesterified fatty acids in the blood serum of patients with acromegaly in various therapeutic effects].
    Balabolkin MI
    Probl Endokrinol Gormonoter; 1966; 12(2):40-4. PubMed ID: 6002141
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of plasma growth hormone levels with glucose infusion in patients with acromegaly.
    Nakagawa K; Obara T
    Clin Endocrinol (Oxf); 1976 Nov; 5(6):713-6. PubMed ID: 1009678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No effect of treatment with sodium valproate on plasma growth hormone in bromocriptine unresponsive acromegaly.
    Nortier JW; Croughs RJ; Schwarz F; Thijssen JH
    Acta Endocrinol (Copenh); 1986 Feb; 111(2):162-4. PubMed ID: 3082095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M; Schopohl J; König A; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.